Researchers investigated if selective blocking of neuropeptide Y (NPY) receptors, NPY1R or NPY2R, using small molecule non-peptide antagonists (BIBP-3222 for NPY1R and BIIE-0246 for NPY2R) in the colon could attenuate intestinal inflammation by lowering TNF levels.
[Inflammatory Bowel Diseases]
7992332
{7992332:AAAAAAAA}
apa
50
1
167626
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
